TABLE 1.
Overview cohorts participating in the psychosocial factors and cancer incidence (PSY‐CA) study
| Name of Cohort | Number of subcohorts included b | Organizations (country) | Number of participants a | Approx. max follow‐up duration (years) for cancer diagnosis | Reference |
|---|---|---|---|---|---|
| Ontario Health Study | 1 | University of Toronto (Canada) | 163,257 | 10 | (Borugian et al., 2010; Dummer et al., 2018) |
| Lifelines | 1 | University Medical Center Groningen (The Netherlands) | 152,000 | 13 | (Scholtens et al., 2015) |
| Nord‐Trøndelag Health Study (HUNT) | 2 | Norwegian University of Science and Technology (Norway) | 62,237 | 13–24 | (Krokstad et al., 2013) |
| CARTaGENE | 1 | Centre Hospitalier Universitaire Sainte Justine (Canada) | 43,000 | 10 | (Awadalla et al., 2013; Borugian et al., 2010; Dummer et al., 2018) |
| Atlantic PATH | 1 | Dalhousie University (Canada) | 34,169 | 10 | (Borugian et al. 2010; Sweeney et al., 2017) |
| European Prospective Investigation into Cancer and Nutrition (MORGEN‐EPIC) | 1 | National Institute for Public Health and the Environment (RIVM) (The Netherlands) | 23,100 | 24 | (Beulens et al., 2010; Riboli, 1992, 2002) |
| Healthy Life in an Urban Setting (HELIUS) | 1 | Amsterdam University Medical Centers and Amsterdam Municipal Health Service (The Netherlands) | 19,932 | 8 | (Snijder et al., 2017; Stronks et al., 2013) |
| European Prospective Investigation into Cancer and Nutrition (Prospect‐EPIC) | 1 | University Medical Center Utrecht (The Netherlands) | 17,357 | 24 | (Beulens et al., 2010; Boker et al., 2001; Riboli, 1992, 2002) |
| Dutch occupational and Environmental Health Cohort Study (AMIGO) | 1 | Utrecht University (The Netherlands) | 14,829 | 5 | (Slottje et al., 2014) |
| Avon Longitudinal Study of Parents and Children (ALSPAC) | 1 | University of Bristol (England) | 14,541 | 20 | (Fraser et al., 2013) |
| Second Manifestations of ARTerial disease (SMART) | 1 | University Medical Center Utrecht (The Netherlands) | 11,881 | 12 | (Simons et al., 1999) |
| Rotterdam Study | 3 | Erasmus MC University Medical Center (The Netherlands) | 11,740 | 8–14 | (Hofman et al., 2015) |
| English Longitudinal Study of Ageing (ELSA) | 1 | University College London (England) | 11,391 | 14 | (Steptoe et al., 2013) |
| Whitehall‐II study (WH‐II) | 1 | University College London (England) | 10,308 | 11 | (Marmot & Brunner, 2005) |
| OMEGA‐II | 1 | The Netherlands Cancer Institute (The Netherlands) | 10,000 | 8 | (van den Belt‐Dusebout et al., 2016; Spaan et al., 2016) |
| Utrecht Health Project (UHP) | 2 | University Medical Center Utrecht (The Netherlands) | 10,000 | 11–19 | (Grobbee et al., 2005) |
| Longitudinal Aging Study Amsterdam (LASA) | 1 | Amsterdam University Medical Centers (The Netherlands) | 4632 | 28 | (Hoogendijk et al., 2016; Huisman et al., 2011) |
| Netherlands Study of Depression and Anxiety (NESDA) | 1 | Amsterdam University Medical Centers, on behalf of the NESDA consortium (www.nesda.nl) (The Netherlands) | 2981 | 15 | (Penninx et al., 2008) |
Note: In some cohorts a measurement wave other than baseline is used in PSY‐CA due to the absence of a measure relating to one of the psychosocial factors outlined in the hypotheses.
a
This is before applying any exclusion criteria (e.g., a history of cancer) and based on baseline adult sample sizes.
b
Subcohorts are limited to those that are treated as subcohorts in the meta‐analyses. For certain cohorts, subcohorts were combined where subsample sizes were too small otherwise (i.e., <1000) and combining resulted in minimal or no loss of data.